Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
7,938,059
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
17,568,471
-
Shares change
-
+1,696,834
-
Total reported value, excl. options
-
$40,229,950
-
Value change
-
-$2,286,455
-
Put/Call ratio
-
215%
-
Number of buys
-
21
-
Number of sells
-
23
-
Price
-
$2.29
Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) as of Q4 2021
As of 31 Dec 2021 X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) had 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 17,568,471 shares of stock of the company.
Largest 10 holders included Bain Capital Life Sciences Investors, LLC, Ikarian Capital, LLC, Point72 Asset Management, L.P., Tri Locum Partners LP, AIGH Capital Management LLC, ORBIMED ADVISORS LLC, AXA S.A., VANGUARD GROUP INC, BVF INC/IL, and Worth Venture Partners, LLC.
This table shows 66 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.